PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 17 | -100.0% | 0.00% | – |
| Q3 2021 | $272,000 | -24.9% | 38,765 | -1.8% | 0.00% | – |
| Q2 2021 | $362,000 | -3.7% | 39,466 | +1.8% | 0.00% | – |
| Q1 2021 | $376,000 | -54.4% | 38,778 | -51.7% | 0.00% | – |
| Q4 2020 | $824,000 | -33.1% | 80,334 | -34.2% | 0.00% | -100.0% |
| Q3 2020 | $1,232,000 | -29.0% | 122,176 | -26.6% | 0.00% | 0.0% |
| Q2 2020 | $1,736,000 | +58.7% | 166,487 | +28.6% | 0.00% | 0.0% |
| Q1 2020 | $1,094,000 | -8.1% | 129,427 | -4.8% | 0.00% | 0.0% |
| Q4 2019 | $1,190,000 | +483.3% | 135,997 | +617.9% | 0.00% | – |
| Q3 2019 | $204,000 | -13.9% | 18,945 | +1.5% | 0.00% | – |
| Q2 2019 | $237,000 | -84.0% | 18,664 | -51.0% | 0.00% | -100.0% |
| Q1 2019 | $1,477,000 | -2.3% | 38,077 | -48.7% | 0.00% | -50.0% |
| Q4 2018 | $1,511,000 | +47.7% | 74,180 | +232.5% | 0.00% | +100.0% |
| Q3 2018 | $1,023,000 | -39.7% | 22,311 | -22.2% | 0.00% | -50.0% |
| Q2 2018 | $1,697,000 | -21.9% | 28,690 | -10.2% | 0.00% | 0.0% |
| Q1 2018 | $2,174,000 | -37.3% | 31,958 | -8.8% | 0.00% | -33.3% |
| Q4 2017 | $3,465,000 | -29.0% | 35,052 | -14.0% | 0.00% | -40.0% |
| Q3 2017 | $4,880,000 | +60.1% | 40,750 | +16.8% | 0.01% | +66.7% |
| Q2 2017 | $3,049,000 | -0.8% | 34,892 | -57.8% | 0.00% | 0.0% |
| Q1 2017 | $3,075,000 | +139.9% | 82,644 | +97.9% | 0.00% | +200.0% |
| Q4 2016 | $1,282,000 | -71.1% | 41,754 | -36.9% | 0.00% | -75.0% |
| Q3 2016 | $4,435,000 | +145.7% | 66,136 | +9.2% | 0.00% | +100.0% |
| Q2 2016 | $1,805,000 | -23.5% | 60,589 | -24.6% | 0.00% | -33.3% |
| Q1 2016 | $2,360,000 | -50.1% | 80,380 | +33.3% | 0.00% | -40.0% |
| Q4 2015 | $4,729,000 | +3.6% | 60,307 | -0.4% | 0.01% | 0.0% |
| Q3 2015 | $4,565,000 | -70.2% | 60,570 | -53.8% | 0.01% | -66.7% |
| Q2 2015 | $15,297,000 | +67.3% | 131,028 | +238.3% | 0.02% | +66.7% |
| Q1 2015 | $9,144,000 | +56.3% | 38,735 | +25.3% | 0.01% | +80.0% |
| Q4 2014 | $5,851,000 | +291.1% | 30,909 | +392.9% | 0.01% | +400.0% |
| Q3 2014 | $1,496,000 | -49.2% | 6,271 | -85.9% | 0.00% | -50.0% |
| Q2 2014 | $2,947,000 | +103.5% | 44,633 | +221.0% | 0.00% | +100.0% |
| Q1 2014 | $1,448,000 | +4.8% | 13,903 | +4.1% | 0.00% | 0.0% |
| Q4 2013 | $1,382,000 | +366.9% | 13,352 | +142.1% | 0.00% | – |
| Q3 2013 | $296,000 | -36.2% | 5,514 | -47.3% | 0.00% | – |
| Q2 2013 | $464,000 | +36.1% | 10,457 | +2.4% | 0.00% | – |
| Q1 2013 | $341,000 | – | 10,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |